Xinghan Wu

974 total citations
27 papers, 724 citations indexed

About

Xinghan Wu is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Xinghan Wu has authored 27 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cancer Research and 6 papers in Biomedical Engineering. Recurrent topics in Xinghan Wu's work include Nanoplatforms for cancer theranostics (6 papers), Sirtuins and Resveratrol in Medicine (4 papers) and Epigenetics and DNA Methylation (4 papers). Xinghan Wu is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Sirtuins and Resveratrol in Medicine (4 papers) and Epigenetics and DNA Methylation (4 papers). Xinghan Wu collaborates with scholars based in China and United States. Xinghan Wu's co-authors include Wentong Li, Chengcheng Gai, Weifen Zhang, Chuanliang Liu, Mengyu Yu, Jie Zheng, Shijun Lv, Dejun Ding, Juan Ge and Qiang Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Colloid and Interface Science.

In The Last Decade

Xinghan Wu

24 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinghan Wu China 14 380 241 235 111 111 27 724
Qian Zhong China 16 420 1.1× 154 0.6× 67 0.3× 30 0.3× 41 0.4× 41 862
Hongying Yang China 19 499 1.3× 189 0.8× 406 1.7× 22 0.2× 176 1.6× 39 1.1k
Dong Hyu Cho South Korea 12 177 0.5× 162 0.7× 90 0.4× 17 0.2× 193 1.7× 49 685
Yuexia Xie China 19 358 0.9× 130 0.5× 138 0.6× 9 0.1× 186 1.7× 27 808
Wencai Guan China 16 356 0.9× 226 0.9× 76 0.3× 10 0.1× 60 0.5× 41 658
Dongxu Wang China 14 362 1.0× 146 0.6× 33 0.1× 35 0.3× 86 0.8× 53 593
Prosenjit Sen India 18 393 1.0× 149 0.6× 57 0.2× 132 1.2× 48 0.4× 48 953

Countries citing papers authored by Xinghan Wu

Since Specialization
Citations

This map shows the geographic impact of Xinghan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinghan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinghan Wu more than expected).

Fields of papers citing papers by Xinghan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinghan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinghan Wu. The network helps show where Xinghan Wu may publish in the future.

Co-authorship network of co-authors of Xinghan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinghan Wu. A scholar is included among the top collaborators of Xinghan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinghan Wu. Xinghan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yanfeng, et al.. (2025). Establishment of a patient‐derived drug‐resistant oral squamous cell carcinoma animal model. Animal Models and Experimental Medicine. 8(8). 1513–1523. 1 indexed citations
2.
Li, Mingfeng, Xinghan Wu, Lin Jiang, et al.. (2025). Exploring the co‐morbid relationship between Alzheimer's disease and lung cancer in the 5xFAD transgenic mouse model. Animal Models and Experimental Medicine. 8(5). 784–797.
4.
Ye, Fan, Mingfeng Li, Min Liu, et al.. (2025). Co-Aggregation of Syndecan-3 with β-Amyloid Aggravates Neuroinflammation and Cognitive Impairment in 5×FAD Mice. International Journal of Molecular Sciences. 26(12). 5502–5502. 2 indexed citations
5.
Liu, Aihua, Min Liu, Mingfeng Li, et al.. (2024). Development of an animal model of hypothyroxinemia during pregnancy in Wistar rats. SHILAP Revista de lepidopterología. 7(6). 926–935.
6.
Wu, Xinghan, Tiejun Zhang, Yining Chen, et al.. (2024). Perspective insights into versatile hydrogels for stroke: From molecular mechanisms to functional applications. Biomedicine & Pharmacotherapy. 173. 116309–116309. 5 indexed citations
7.
Liu, Min, Xueling Zhang, Tian Fan, et al.. (2024). Interleukin-6 deficiency reduces neuroinflammation by inhibiting the STAT3-cGAS-STING pathway in Alzheimer’s disease mice. Journal of Neuroinflammation. 21(1). 282–282. 21 indexed citations
8.
Zhang, Weidong, Xin Ye, Mei Jiang, et al.. (2024). Disturbance of mitochondrial dynamics in myocardium of broilers with pulmonary hypertension syndrome. British Poultry Science. 65(2). 154–164. 2 indexed citations
9.
Chen, Yining, Xinghan Wu, Zhongxiang Bai, et al.. (2024). Facile Double-Injection Strategy for the Engineering of Versatile Multiresponsive Hydrogels Encapsulating Drug-Loaded Micelles for Promoting Diabetic Wound Healing. Industrial & Engineering Chemistry Research. 63(6). 2570–2583. 2 indexed citations
10.
Wu, Xinghan, Liping Zhao, Mingxia Jiang, et al.. (2022). Co-loaded lapatinib/PAB by ferritin nanoparticles eliminated ECM-detached cluster cells via modulating EGFR in triple-negative breast cancer. Cell Death and Disease. 13(6). 557–557. 45 indexed citations
11.
Zhao, Liping, Xiaoxia Wang, Han Lou, et al.. (2022). Buffet-style Cu(II) for enhance disulfiram-based cancer therapy. Journal of Colloid and Interface Science. 624. 734–746. 29 indexed citations
12.
Jiang, Mingxia, Liping Zhao, Xiao-Ming Cui, et al.. (2021). Cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy. Journal of Advanced Research. 35. 49–60. 26 indexed citations
13.
Zhao, Liping, Mingxia Jiang, Zhilu Xu, et al.. (2021). Selective thermotherapy of tumor by self-regulating photothermal conversion system. Journal of Colloid and Interface Science. 605. 752–765. 23 indexed citations
14.
Zhu, Shuai, Xinghan Wu, Yuan Liu, et al.. (2021). NAMPT reduction‐induced NAD+ insufficiency contributes to the compromised oocyte quality from obese mice. Aging Cell. 20(11). e13496–e13496. 28 indexed citations
15.
Zhang, Dong, Weifen Zhang, Xinghan Wu, et al.. (2021). Dual Modal Imaging-Guided Drug Delivery System for Combined Chemo-Photothermal Melanoma Therapy. International Journal of Nanomedicine. Volume 16. 3457–3472. 18 indexed citations
16.
Wu, Xinghan, Wenyu Wang, Chengcheng Gai, et al.. (2021). Fe(II) and Tannic Acid-Cloaked MOF as Carrier of Artemisinin for Supply of Ferrous Ions to Enhance Treatment of Triple-Negative Breast Cancer. Nanoscale Research Letters. 16(1). 37–37. 53 indexed citations
17.
Wu, Xinghan, et al.. (2021). [MiR-300 inhibits invasion and metastasis of osteosarcoma cell MG63 by negatively regulating PTTG1].. PubMed. 41(2). 285–291. 5 indexed citations
18.
Gai, Chengcheng, Chuanliang Liu, Xinghan Wu, et al.. (2020). MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells. Cell Death and Disease. 11(9). 751–751. 189 indexed citations
19.
Li, Congyang, Xi He, Longsen Han, et al.. (2020). Melatonin ameliorates the advanced maternal age-associated meiotic defects in oocytes through the SIRT2-dependent H4K16 deacetylation pathway. Aging. 12(2). 1610–1623. 35 indexed citations
20.
Wang, Yang, et al.. (2020). Vector‐fitting‐based quantitative SSCI analysis for series‐compensated wind power systems. IET Renewable Power Generation. 14(15). 3023–3034. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026